General Information
Drug ID
DR00466
Drug Name
Ivacaftor
Synonyms
Kalydeco (TN)
Drug Type
Small molecular drug
Indication Cystic fibrosis [ICD11: CA25] Approved [1]
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=16220172"></iframe>
3D MOL 2D MOL
Formula
C24H28N2O3
Canonical SMILES
CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C
InChI
InChI=1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29)
InChIKey
PURKAOJPTOLRMP-UHFFFAOYSA-N
CAS Number
CAS 873054-44-5
Pharmaceutical Properties Molecular Weight 392.499 Topological Polar Surface Area 78.4
Heavy Atom Count 29 Rotatable Bond Count 4
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 4
PubChem CID
16220172
PubChem SID
104253162 , 118855344 , 123051083 , 124757031 , 124950685 , 125163835 , 125299328 , 125434146 , 126661313 , 126731535 , 131480767 , 134964550 , 135264255 , 135626653 , 135653729 , 135692075 , 135727452 , 136367331 , 136367911 , 136926964 , 137031731 , 137626819 , 137626820 , 144116089 , 152134181 , 152258419 , 160645564 , 160647255 , 160874442 , 162011579 , 162037465 , 162202744 , 163894050 , 164042021 , 172919866 , 175266660 , 175427103 , 178101159 , 184819711 , 187072829 , 198993065 , 223381530 , 223471420 , 223683825 , 223705162 , 224174132 , 226685555 , 24902571 , 28764112 , 40723266
ChEBI ID
ChEBI:66901
TTD Drug ID
D0W7WC
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Ivacaftor was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Investigation of the effects of the CFTR potentiator ivacaftor on human P-glycoprotein (ABCB1). Sci Rep. 2017 Dec 13;7(1):17481.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.